Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-10-13 Purchase |
2021-10-15 10:51 am |
Big Cypress Acquisition Corp. | BCYP | Katz Ilan Director 10% Owner |
500 | $10.11 | $5,053 | 3,049,325 (Indirect Direct) |
View |
2021-10-14 Purchase |
2021-10-15 10:48 am |
Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner |
1,000 | $10.11 | $10,110 | 3,048,825 (Indirect Direct) |
View |
2021-10-01 Purchase |
2021-10-05 5:00 pm |
Big Cypress Acquisition Corp. | BCYP | Spragens Jeffrey G Director |
13,000 | $10.07 | $130,910 | 13,000 (Direct) |
View |
2021-10-01 Purchase |
2021-10-05 5:00 pm |
Big Cypress Acquisition Corp. | BCYP | Katz Ilan Director 10% Owner |
1,000 | $10.09 | $10,090 | 3,048,825 (Indirect Direct) |
View |
2021-01-14 Purchase |
2021-01-14 1:33 pm |
Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner |
417,200 | $10 | $4,172,000 | 3,047,825 (Indirect) |
View |
2021-01-14 Purchase |
2021-01-14 1:32 pm |
Big Cypress Acquisition Corp. | BCYP | Katz Ilan Director 10% Owner |
417,200 | $10 | $4,172,000 | 3,047,825 (Indirect) |
View |
2021-01-14 Purchase |
2021-01-14 1:30 pm |
Big Cypress Acquisition Corp. | BCYP | Big Cypress Holdings LLC CEO and CFO 10% Owner |
417,200 | $10 | $4,172,000 | 3,047,825 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-10-22 Option Award |
2021-10-26 9:52 pm |
N/A 2024-08-05 |
SAB Biotherapeutics Inc. | SABS | Wu Hua SVP Research & Product Dev. |
116,524 | $0 | 116,524 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:52 pm |
N/A 2031-01-01 |
SAB Biotherapeutics Inc. | SABS | Polvino William James Director |
151,333 | $0 | 151,333 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:51 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Finnegan Frederick Chief Business Officer |
263,232 | $0 | 263,232 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:51 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Hamilton Edward D. 10% Owner |
14,937,369 | $0 | 9,967,964 (Direct) |
View |
2021-10-12 Option Award |
2021-10-26 9:51 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Hamilton Edward D. 10% Owner |
25,000 | $10.08 | 9,967,964 (Indirect) |
View |
2021-10-01 Option Award |
2021-10-26 9:51 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Hamilton Edward D. 10% Owner |
28,587 | $10.1 | 9,967,964 (Direct) |
View |
2021-10-12 Option Award |
2021-10-26 9:51 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Hamilton Edward D. 10% Owner |
25,000 | $10.09 | 9,967,964 (Indirect) |
View |
2021-10-22 Option Award |
2021-10-26 9:50 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Luke Thomas Charles Chief Medical Officer |
219,930 | $0 | 219,930 (Direct) |
View |
2021-10-19 Option Award |
2021-10-26 9:50 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Luke Thomas Charles Chief Medical Officer |
990 | $10.1 | 219,930 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:50 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer 10% Owner |
8,006,048 | $0 | 2,795,084 (Direct) |
View |
2021-10-07 Option Award |
2021-10-26 9:50 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer 10% Owner |
2,800 | $10.07 | 2,795,084 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:49 pm |
N/A 2031-01-01 |
SAB Biotherapeutics Inc. | SABS | Turner Mervyn Director |
79,192 | $0 | 79,192 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:49 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Link David Charles Director |
149,483 | $0 | 149,483 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:48 pm |
N/A 2027-03-27 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
375,625 | $0 | 375,625 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:48 pm |
N/A 2030-04-27 |
SAB Biotherapeutics Inc. | SABS | Ullerich Melissa Vera Chief Communications Officer |
220,817 | $0 | 220,817 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:48 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
14,937,369 | $0 | 9,913,018 (Direct) |
View |
2021-10-12 Option Award |
2021-10-26 9:48 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
25,000 | $10.08 | 9,913,018 (Indirect) |
View |
2021-10-01 Option Award |
2021-10-26 9:48 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
28,587 | $10.1 | 9,913,018 (Indirect) |
View |
2021-10-12 Option Award |
2021-10-26 9:48 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
25,000 | $10.09 | 9,913,018 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:47 pm |
N/A 2024-08-05 |
SAB Biotherapeutics Inc. | SABS | Pommer Jerry Lynn Chief Compliance Officer |
128,202 | $0 | 128,202 (Direct) |
View |
2021-10-22 Option Award |
2021-10-26 9:46 pm |
N/A 2024-11-05 |
SAB Biotherapeutics Inc. | SABS | Randall Charles Hiram Chief Strategy Officer |
506,276 | $0 | 506,276 (Direct) |
View |
Ownership |
2021-10-22 9:27 pm |
N/A N/A |
Big Cypress Acquisition Corp. | SABS | Hamilton Edward D. 10% Owner |
0 | $0 | 78,587 (Direct) |
View |
Ownership |
2021-10-22 9:25 pm |
N/A N/A |
Big Cypress Acquisition Corp. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
0 | $0 | 78,587 (Direct) |
View |
Ownership |
2021-10-22 9:24 pm |
N/A N/A |
Big Cypress Acquisition Corp. | SABS | Sullivan Eddie Joe Chief Executive Officer 10% Owner |
0 | $0 | 2,800 (Direct) |
View |
Ownership |
2021-10-22 9:23 pm |
N/A N/A |
Big Cypress Acquisition Corp. | SABS | Luke Thomas Charles Chief Medical Officer |
0 | $0 | 990 (Direct) |
View |
Ownership |
2021-10-22 9:22 pm |
N/A N/A |
Big Cypress Acquisition Corp. | SABS | Beyer Russell P Chief Financial Officer |
0 | $0 | 2,475 (Direct) |
View |
Ownership |
2021-01-11 5:03 pm |
N/A N/A |
Big Cypress Acquisition Corp. | BCYP | Big Cypress Holdings LLC 10% Owner |
0 | $0 | 2,630,625 (Direct) |
View |
Ownership |
2021-01-11 5:00 pm |
N/A N/A |
Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner |
0 | $0 | 2,630,625 (Indirect) |
View |